Published in Oncology Business Week, July 2nd, 2006
Researchers at the Henry Ford Health System in Detroit report, "The economics of breast cancer recurrence are poorly understood. For this retrospective cohort study, we evaluated the economic burden of breast cancer recurrence by using data from a large Midwestern healthcare system."
L. Lamerato and colleagues described their study: "Women with Stage I or II breast cancer (according to the American Joint Commission on Cancer staging criteria) were identified from the tumor registry of the Henry Ford Health System. The economic burden of breast cancer recurrence was...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Oncology Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.